Stock Taper Revenue: $33.6 million, down 45% year-over-year.
GAAP Net Loss: $23.6 million, compared to a loss of $17.4 million in Q2 2025.
Adjusted EBITDA: Loss of $21.8 million, worsening from a loss of $14.1 million in the prior year.
Operating Cash Flow: Negative $5 million, an improvement from negative $41.2 million in Q2 2025.
Non-GAAP Operating Expenses: Declined by 25% to $58.6 million.
Commission Revenue: Totaled $29.8 million, including $7.6 million in tail revenue, down from $17.8 million a year ago.
Medicare Segment Revenue: $31.8 million, down 45%, reflecting lower enrollment and tail revenue.
Cash Position: Ended the quarter with $101 million in cash equivalents and short-term marketable securities.
Lifetime Advisory Model: Launched in Q2, aimed at enhancing member engagement and retention through ongoing support rather than one-time interactions.
Cost Reduction Initiatives: Significant reductions in marketing and operational expenses, with variable marketing costs down 45%.
AI Integration: AI is being utilized for customer service and operational efficiencies, with plans to automate more processes.
ICHRA Focus: Continued investment in the under-65 market through the Individual Coverage Health Reimbursement Arrangement (ICHRA), though revenue from this segment is expected to remain below $5 million for 2026.
2026 Expectations: Maintaining guidance for revenue, GAAP net income, adjusted EBITDA, and operating cash flow, with expectations for improved cash flow and cost savings.
Long-term Growth: Projecting a return to sustainable revenue growth in 2027, driven by the transition to relationship-based economics, growth in ICHRA, and expansion of the carrier-dedicated business.
Enrollment Decline: Significant year-over-year declines in Medicare enrollments and revenue, attributed to strategic shifts in marketing spend and focus on member engagement.
Increased Costs: Per-member acquisition costs rose by 16%, with customer care and enrollment costs per member increasing by 42%.
Market Volatility: Uncertainty remains regarding the Medicare Advantage (MA) market, with potential for elevated churn rates and varying commission strategies among carriers.
Negative Adjustments: Continued GAAP net losses and adjusted EBITDA losses indicate ongoing financial challenges.
Broker Commission Environment: Expectations for varied commission strategies among carriers for 2027, with no significant changes anticipated in non-commissionable plans.
Marketing Spend Strategy: Plans to further reduce marketing spend in Q3 to allow advisers to focus on member engagement, which may lead to lower commission revenue in the short term.
Retention and Churn: Discussions around potential elevated churn rates in the MA market, with mixed signals from carriers regarding retention expectations.
Balance Sheet Management: Ongoing conversations regarding balance sheet optimization and potential resolutions with stakeholders, particularly concerning convertible debt. Overall, eHealth is navigating a challenging environment as it transitions to a new operational model while focusing on cost reductions and member engagement strategies. The company remains optimistic about long-term growth despite current financial pressures.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT